CoChat
Sign Up
Cited by 43

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Modifications in P62 occur due to proteasome inhibition in alcoholic liver disease

Bardag-Gorce, Fawzia, Francis, Tricia, Nan, Li, Li, Jun, He Lue, Yan, French, Barbara A., French, Samuel W.·2005·Life Sciences
DOI 10.1016/j.lfs.2005.04.020
Open this paper in CoChat — free account

Abstract

P62 is capable of binding the polyubiquitin chain that targets proteins for degradation by the proteasome through its ubiquitin associated domain (UBA). Immunostaining of hepatocytes from human liver with alcoholic hepatitis showed colocalization of ubiquitin and P62 in Mallory bodies. Rats fed ethanol chronically and their controls showed that P62 is colocalized with the proteasome in hepatocytes as shown by confocal microscopy. P62 cosedimented with 26S proteasomes isolated from livers of control and alcohol fed rats. P62 was increased in the 26S proteasome fraction when the proteasome chymotrypsin-like (ChT-L) activity decreased in rats fed ethanol. PS-341, a potent proteasome inhibitor was used to compare the inhibition of the proteasome with the inhibition which occurs with ethanol feeding. P62 protein levels were also increased in the purified proteasome fraction of rats given PS-341. This data indicates that modifications in P62 occur due to proteasome inhibition in experimental alcoholic liver disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.lfs.2005.04.020

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 19

  1. Bardag-Gorce, 2002, The role of the ubiquitin–proteasome pathway in the formation of Mallory bodies, Experimental and Molecular Pathology, 73, 75, 10.1006/exmp.2002.2451 · DOI
  2. Bardag-Gorce, 2003, Mechanism of cytokeratin aggresome formation: the role of mutant ubiquitin (UBB+1), Experimental and Molecular Pathology, 74, 160, 10.1016/S0014-4800(02)00024-2 · DOI
  3. Bardag-Gorce, 2003, Changes in P62 in the liver of alcohol fed rats: involvement with the ubiquitin–pathway, FASEB Journal, 17, A255
  4. Bardag-Gorce, 2004, The proteasome inhibitor, PS-341, causes cytokeratin aggresome formation, Experimental and Molecular Pathology, 76, 9, 10.1016/j.yexmp.2003.08.006 · DOI
  5. Bradford, 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding, Analytical Biochemistry, 72, 248, 10.1016/0003-2697(76)90527-3 · DOI · Paper page
  6. Donohue, 2004, Decreased proteasome activity is associated with increased severity of liver pathology and oxidative stress in experimental alcoholic liver disease, Alcohol Clinical Experimental Research, 28, 1257, 10.1097/01.ALC.0000134233.89896.19 · DOI
  7. Fataccioli, 1999, Effects of chronic ethanol administration on rat liver proteasome activities: relationship with oxidative stress, Hepatology, 29, 14, 10.1002/hep.510290106 · DOI
  8. Geetha, 2002, Structure and functional properties of the ubiquitin binding protein P62, FEBS Letters, 512, 19, 10.1016/S0014-5793(02)02286-X · DOI
  9. Kuusisto, 2002, Early accumulation of P62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation, Neuropathology and Applied Neurobiology, 28, 228, 10.1046/j.1365-2990.2002.00394.x · DOI
  10. Kuusisto, 2001, Ubiquitin-binding protein P62 expression is induced during apoptosis and proteasomal inhibition in neuronal cells, Biochemical and Biophysical Research Communications, 280, 223, 10.1006/bbrc.2000.4107 · DOI · Paper page
  11. Li, 2000, Mechanism of the alcohol cyclic pattern: role of the hypothalamic–pituitary–thyroid axis, American Journal of Physiology: Gastrointestinal and Liver Physiology, 279, G118
  12. Muller, 2004, Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis, Hepatology, 39, 963, 10.1002/hep.20108 · DOI
  13. Nakaso, 2004, Transcriptional activation of P62/A170/ZIP during the formation of the aggregates: possible mechanisms and the role in Lewy body formation in Parkinson's disease, Brain Research, 1012, 42, 10.1016/j.brainres.2004.03.029 · DOI · Paper page
  14. Nan, 2004, P62 is involved in the mechanism of Mallory body formation, Experimental and Molecular Pathology, 77, 168, 10.1016/j.yexmp.2004.06.003 · DOI
  15. Riley, 2002, The Mallory body as an aggresome: in vitro studies, Experimental and Molecular Pathology, 72, 17, 10.1006/exmp.2001.2413 · DOI
  16. Seibenhener, 2004, Sequestosome 1/P62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation, Molecular and Cellular Biology, 24, 8055, 10.1128/MCB.24.18.8055-8068.2004 · DOI
  17. Stumptner, 2002, Mallory body—a disease-associated type of sequestosome, Hepatology, 35, 1053, 10.1053/jhep.2002.32674 · DOI
  18. Yuan, 1996, Mallory body induction in drug-primed mouse liver, Hepatology, 24, 603, 10.1002/hep.510240324 · DOI
  19. Zatloukal, 2002, P62 is a common component of cytoplasmic inclusions in protein aggregation diseases, American Journal of Pathology, 160, 255, 10.1016/S0002-9440(10)64369-6 · DOI · Paper page

Cited by

Sorted by citations

See all 43

Metadata

Authors
Bardag-Gorce, F., Francis, T., Nan, L., Li, J., He Lue, Y., French, B. A., & French, S. W.
Venue
Life Sciences
Publisher
Elsevier BV
Published
2005-09
Volume
77
Issue
20
Pages
2594-2602
ISSN
0024-3205
DOI
10.1016/j.lfs.2005.04.020
Cited by
43
References
1
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review